A detailed history of Consolidated Portfolio Review Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 3,696 shares of JNJ stock, worth $574,358. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,696
Previous 3,716 0.54%
Holding current value
$574,358
Previous $543 Million 10.28%
% of portfolio
0.13%
Previous 0.13%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$145.48 - $167.38 $2,909 - $3,347
-20 Reduced 0.54%
3,696 $599 Million
Q2 2024

Jul 31, 2024

BUY
$144.38 - $157.78 $97,167 - $106,185
673 Added 22.12%
3,716 $543 Million
Q1 2024

Apr 30, 2024

SELL
$155.22 - $162.74 $111,758 - $117,172
-720 Reduced 19.13%
3,043 $481 Million
Q4 2023

Jan 29, 2024

SELL
$145.6 - $158.88 $73,091 - $79,757
-502 Reduced 11.77%
3,763 $590 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $1,090 - $1,221
7 Added 0.16%
4,265 $664 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $11,576 - $12,458
75 Added 1.79%
4,258 $705 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $631,842 - $754,027
4,183 New
4,183 $648 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Consolidated Portfolio Review Corp Portfolio

Follow Consolidated Portfolio Review Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Portfolio Review Corp with notifications on news.